Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reactivating the phototransduction cascade with a mutation agnostic gene therapy preserves vision in rod-cone dystrophies.

iScience·2025
Same author

Lessons learned from the RE(ACT) conference on medical devices for rare diseases.

European journal of medical genetics·2024
Same author

The vertical position of visual information conditions spatial memory performance in healthy aging.

Communications psychology·2024
Same author

Incidence and risk factors of fellow-eyes wet conversion in unilateral neovascular age-related macular degeneration over 15-year follow-up.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2024
Same author

ADAPTIVE OPTICS AND MULTIMODAL IMAGING FOR INFLAMMATORY VITREORETINAL INTERFACE ABNORMALITIES.

Retina (Philadelphia, Pa.)·2024
Same author

The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD.

Nature communications·2024

Related Experiment Video

Updated: Apr 16, 2026

Author Spotlight: Manipulating Signaling in Zebrafish Embryos to Decode Cell Fate Decisions
07:18

Author Spotlight: Manipulating Signaling in Zebrafish Embryos to Decode Cell Fate Decisions

Published on: October 27, 2023

3.6K

Optogenetics.

Jens Duebel1, Katia Marazova, José-Alain Sahel

  • 1aInstitut de la Vision, Sorbonne Universités, UPMC Univ Paris, UMR_S 968 bINSERM, U_968 cCNRS, UMR_7210 dCentre Hospitalier National d'Ophtalmologie des Quinze-Vingts, DHU ViewMaintain, INSERM-DHOS CIC 1423 eFondation Ophtalmologique Rothschild, Paris, France fInstitute of Ophthalmology-University College London, London, UK.

Current Opinion in Ophthalmology
|March 12, 2015
PubMed
Summary
This summary is machine-generated.

Recent advances in optogenetics offer new hope for vision restoration. Novel microbial opsins and efficient viral vectors show promise for treating retinal degenerative diseases.

More Related Videos

Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo
07:19

Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo

Published on: August 4, 2021

5.5K
In vivo Optogenetic Stimulation of the Rodent Central Nervous System
09:37

In vivo Optogenetic Stimulation of the Rodent Central Nervous System

Published on: January 15, 2015

61.1K

Related Experiment Videos

Last Updated: Apr 16, 2026

Author Spotlight: Manipulating Signaling in Zebrafish Embryos to Decode Cell Fate Decisions
07:18

Author Spotlight: Manipulating Signaling in Zebrafish Embryos to Decode Cell Fate Decisions

Published on: October 27, 2023

3.6K
Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo
07:19

Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo

Published on: August 4, 2021

5.5K
In vivo Optogenetic Stimulation of the Rodent Central Nervous System
09:37

In vivo Optogenetic Stimulation of the Rodent Central Nervous System

Published on: January 15, 2015

61.1K

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Biotechnology

Background:

  • Retinal degenerative diseases cause irreversible vision loss.
  • Optogenetics offers a potential strategy for restoring vision by genetically modifying cells to become light-sensitive.

Purpose of the Study:

  • To review recent developments in optogenetics.
  • To discuss potential applications in ophthalmology for vision restoration in retinal degenerative diseases.

Main Methods:

  • Review of recent scientific literature on optogenetics and ocular gene therapy.
  • Focus on novel opsins and viral vector technologies.

Main Results:

  • Significant advances in optogenetics have yielded novel microbial opsins with enhanced light sensitivity and red-shifted spectra.
  • These opsins can be stimulated at safe light levels for the human eye.
  • Highly efficient viral vectors for ocular gene delivery have been developed.

Conclusions:

  • Novel optogenetic tools and viral vectors are now available for ocular gene delivery.
  • These advancements create opportunities for developing optogenetic strategies to restore vision.